Possibia

330

Last Update Posted: 2017-05-04

Recruiting has ended

All Genders

accepted

18 Years-65 Years

0 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers

not available at this time

Eligibility

Relevant conditions:

Heroin Dependence

Opioid-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov